Eagle Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.96M | Buy |
+54,691
| New | +$2.96M | 0.02% | 439 |
|
|
2023
Q4 | – | Sell |
-136,917
| Closed | -$7.95M | – | 563 |
|
|
2023
Q3 | $7.95M | Sell |
136,917
-756
| -0.5% | -$43.9K | 0.05% | 293 |
|
|
2023
Q2 | $8.8M | Buy |
137,673
+10,957
| +9% | +$701K | 0.05% | 279 |
|
|
2023
Q1 | $8.78M | Buy |
126,716
+5,593
| +5% | +$388K | 0.05% | 265 |
|
|
2022
Q4 | $8.75M | Sell |
121,123
-220
| -0.2% | -$15.9K | 0.05% | 254 |
|
|
2022
Q3 | $8.63M | Sell |
121,343
-2,211
| -2% | -$157K | 0.06% | 255 |
|
|
2022
Q2 | $9.51M | Sell |
123,554
-2,773
| -2% | -$214K | 0.06% | 249 |
|
|
2022
Q1 | $9.23M | Buy |
126,327
+1,729
| +1% | +$126K | 0.05% | 284 |
|
|
2021
Q4 | $7.79M | Buy |
124,598
+1,320
| +1% | +$82.5K | 0.03% | 353 |
|
|
2021
Q3 | $7.29M | Sell |
123,278
-1,346
| -1% | -$79.6K | 0.03% | 363 |
|
|
2021
Q2 | $8.33M | Buy |
124,624
+395
| +0.3% | +$26.4K | 0.04% | 360 |
|
|
2021
Q1 | $7.82M | Buy |
124,229
+118,796
| +2,187% | +$7.48M | 0.03% | 365 |
|
|
2020
Q4 | $336K | Sell |
5,433
-119,892
| -96% | -$7.41M | ﹤0.01% | 486 |
|
|
2020
Q3 | $7.51M | Sell |
125,325
-2,482
| -2% | -$149K | 0.04% | 319 |
|
|
2020
Q2 | $7.39M | Buy |
127,807
+975
| +0.8% | +$56.4K | 0.04% | 317 |
|
|
2020
Q1 | $7.07M | Buy |
126,832
+35,268
| +39% | +$1.97M | 0.04% | 319 |
|
|
2019
Q4 | $5.88M | Buy |
+91,564
| New | +$5.88M | 0.03% | 387 |
|